| Marc A Vala, MD | |
|
501 N Lansdowne Ave, Drexel Hill, PA 19026 | |
| (610) 284-8216 | |
| (610) 284-8144 |
| Full Name | Marc A Vala |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 501 N Lansdowne Ave, Drexel Hill, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386685394 | NPI | - | NPPES |
| 0018145600001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD066117L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crozer Chester Medical Center | Upland, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Health Access Network Inc | 5698065142 | 196 |
News Archive
Although monthly premiums will go down next year for Medicare prescription drug coverage on average, seniors in the most popular plans will see sizable jumps -; notably a 14 percent hike for the 4.7 million in United Healthcare's plans, a new study says.
Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.
The Department of State, USAID, and the Millennium Challenge Corporation (MCC) on Thursday "announce[d] the first major update of the Foreign Assistance Dashboard," according to a State Department media note.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
Host genetics play a role in disease progression and prognosis. A paper recently uploaded to the preprint server medRxiv by Dubé et al. (1st March 2021) identifies several alleles associated with the gene natriuretic peptide receptor C (NPR3) that may impact disease severity.
› Verified 1 days ago
| Entity Name | Prospect Health Access Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568819084 PECOS PAC ID: 5698065142 Enrollment ID: O20160613000737 |
News Archive
Although monthly premiums will go down next year for Medicare prescription drug coverage on average, seniors in the most popular plans will see sizable jumps -; notably a 14 percent hike for the 4.7 million in United Healthcare's plans, a new study says.
Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.
The Department of State, USAID, and the Millennium Challenge Corporation (MCC) on Thursday "announce[d] the first major update of the Foreign Assistance Dashboard," according to a State Department media note.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
Host genetics play a role in disease progression and prognosis. A paper recently uploaded to the preprint server medRxiv by Dubé et al. (1st March 2021) identifies several alleles associated with the gene natriuretic peptide receptor C (NPR3) that may impact disease severity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marc A Vala, MD Po Box 95000-1595, Philadelphia, PA 19195-1595 Ph: (610) 284-8215 | Marc A Vala, MD 501 N Lansdowne Ave, Drexel Hill, PA 19026 Ph: (610) 284-8216 |
News Archive
Although monthly premiums will go down next year for Medicare prescription drug coverage on average, seniors in the most popular plans will see sizable jumps -; notably a 14 percent hike for the 4.7 million in United Healthcare's plans, a new study says.
Bone strength and heart health are two of the most important health issues for women. One out of every two women will have an osteoporosis-related fracture in her lifetime and more than 50 million women have blood cholesterol levels high enough to pose a risk for heart disease. Now there is a new product available to help address both of these issues at the same time.
The Department of State, USAID, and the Millennium Challenge Corporation (MCC) on Thursday "announce[d] the first major update of the Foreign Assistance Dashboard," according to a State Department media note.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Food and Drug Administration has designated XOMA 052, an antibody to interleukin-1 beta, an orphan drug for the treatment of Behcet's disease. As previously announced, the Committee for Orphan Medical Products of the European Medicines Agency has recommended the granting of orphan medicinal product designation for XOMA 052 for the same indication in the European Union.
Host genetics play a role in disease progression and prognosis. A paper recently uploaded to the preprint server medRxiv by Dubé et al. (1st March 2021) identifies several alleles associated with the gene natriuretic peptide receptor C (NPR3) that may impact disease severity.
› Verified 1 days ago
Lawrence Matthews, Pathology Medicare: Not Enrolled in Medicare Practice Location: 501 N Lansdowne Avenue, Drexel Hill, PA 19026 Phone: 610-284-8217 Fax: 610-284-8144 | |
Steven A Monte, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 501 N Lansdowne Ave, Drexel Hill, PA 19026 Phone: 610-284-8213 Fax: 610-284-8144 |